Back to UBS Group AG UBS Group AG

INOINO
Showing 8 of 10 quarters

Position history for UBS Group AGUBS Group AG's holdings in INOVIO PHARMACEUTICALS INC

UBS Group AG holds 262,320 shares of INO (INOVIO PHARMACEUTICALS INC), worth $288,552 as of 2026-Q2. The position was increased (+5.1% shares).

Current Value

$288,552

Current Shares

262,320

Total Value Change

+$209,280

Total Shares Change

+248,605

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
262,320
+5.1%
$288,5520.0%$1.10
17
2026-Q1
Increased
249,650
+46.4%
$434,3920.0%$1.68
33
2025-Q4
Decreased
170,579
-41.8%
$296,8080.0%$1.76
0
2025-Q3
Increased
293,062
+46.8%
$685,7650.0%$2.44
34
2025-Q2
Decreased
199,679
-3.9%
$406,3480.0%$2.11
0
2025-Q1
Increased
207,867
+17.5%
$338,8230.0%$1.73
28
2024-Q4
Increased
176,974
+1190.4%
$323,8630.0%$1.78
38
2024-Q3
Decreased
13,715
-49.9%
$79,2720.0%$5.86
0

Other major holders of INO: FMR LLC, BlackRock Finance, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used